Immuneering CEO Ben Zeskind to speak at the 4th Translational Medicine Conference

October 25, 2012 — Immuneering’s CEO (Ben Zeskind, PhD, MBA) will moderate a plenary session at the 4th Translational Medicine Conference, and give a talk entitled “Predicting Response and Understanding Mechanism: Identifying Difficult-To-Find Patterns In Biological Data.” Immuneering is also proud to provide financial support for (and attend) the 27th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) and Associated Programs, taking place October 26-28th.